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Introduction
There is a severe shortage of dermatologists in sub-Saharan Africa, with many areas having
no dermatologists at all.[1] Furthermore, there is an increased prevalence of skin disease in
HIV patients, with many conditions being unique to this population or more severe than in
immunocompetent patients.[2] The presence of many of these conditions may affect HIV
management.[3,4] Store-and-forward teledermatology offers a method for increasing access
to skin specialists. Although many areas have limited computer connectivity, mobile phone
networks are more accessible.[5,9] Mobile teledermatology uses mobile phones to perform
store-and-forward teledermatology consultations. Studies evaluating patient acceptability of
conventional store-and-forward teledermatology have been conducted in various study
populations.[6,7,8] However, it is unknown whether patients, particularly those infected
with HIV in resource-limited settings such as southern Africa, find the use of mobile phones
acceptable for collecting their health information and would be willing to receive skin care
through this method. It is possible that patients with a socially stigmatizing condition such as
HIV have additional privacy concerns or that they may feel concerned about transmission of
sensitive information by mass telecommunication technologies. While several studies have
evaluated patient acceptance of store-and-forward teledermatology in industrialized
countries, we were unable to find any studies on patient acceptance in resource poor settings
among patients with HIV.[8,9,10,11] We have investigated whether the use of mobile
teledermatology technology in a resource-limited setting in Botswana was culturally
acceptable to HIV positive patients.
Survey
We conducted a cross-sectional survey of adult patients with HIV and mucocutaneous
complaints in Botswana. Survey questions were developed by physicians in Botswana and
the US, and were vetted by dermatologists with clinical experience in Botswana for face and
content validity. The survey questions were tested with HIV positive outpatients at the
dermatology clinic at the Princess Marina Hospital in Gaborone, Botswana. The study was
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approved by the appropriate ethics committees and the Botswana Ministry of Health. The
study was conducted in consecutively recruited HIV positive patients in Botswana. The
patients were at least 18 years old and presented with a skin or mucosal complaint that had
not been previously evaluated by a dermatologist. The patients were recruited from the
medical and oncology wards, the dermatology clinic, and the Infectious Disease Care Centre
at the Princess Marina Hospital; from the Independence Surgery Center, a private primary
care clinic in Gaborone; and from the outpatient clinics and medical wards at Athlone
Hospital in Lobatse over a 5-week period from August 2009. Enrolled patients received both
a face-to-face and mobile teledermatology evaluation and were afterwards asked to complete
a questionnaire on their attitudes to mobile teledermatology at the end of the doctor-patient
encounter. A Setswana-speaking nurse obtained consent, clarified any patient questions and
administered the questionnaire in Setswana to patients unable to read English. Patients who
were comfortable reading and writing in English completed the questionnaire on their own if
they chose to do so. Enrolled patients received 30 pula (US $4.5) compensation to cover the
cost of their travel.
We screened 89 patients, of whom 77 (87%) were recruited and 75 completed the survey
(97% completion rate), see Table 1. Two patients agreed to participate but could not
complete the survey due to nausea from chemotherapy. Most patients (71%) were 31–50
years old. Thirty four (44%) were males. Most patients were single (71%). A significant
proportion of patients was unemployed (44%) or received their regular skin care outside
Gaborone (39%). The majority of patients stated that time (76%), costs (57%) and distance
(41%) were the major barriers in seeking medical care for their skin conditions (Table 2).
Forty five percent of patients stated that it took 1–3 h to see a skin specialist, while 53% of
patients stated that it took more than 3 h. If privacy was guaranteed, 99% of patients
reported that they would be completely comfortable with a mobile teledermatology
consultation, while only one patient stated that he or she would have to think about it, and
none stated that they would be uncomfortable. When asked what their greatest concern was
regarding mobile phone skin consultations, 82% of patients reported none, while 8%
reported concerns over not having a face-to-face interaction with the physician and an equal
number (n=6) reported concerns over an incomplete representation of their skin or poor
photograph quality (Table 2). The majority of patients (91%) believed that they would
receive the same treatment and quality of care via mobile teledermatology consultation as
with a face-to-face interaction. Most patients were willing to wait 1–3 days (40%) or up to
one week (27%) to receive a response from the mobile teledermatology consultation in
exchange for the convenience of not having to travel to see a skin specialist. When asked
which body sites patients were willing to accept having a mobile teledermatology
consultation for, 58% of patients said that photography of the face was acceptable, 97%
accepted photography of the chest, 92% accepted photography of the genitals, 96% accepted
photographs of the legs and 95% accepted photography of the body as a whole. There was a
significant difference between the acceptability of mobile consultation for lesions on the
face versus all the other body sites (all P-values<0.01). There was no significant difference
for any body site by age or sex (P=0.15–0.75). Most patients cited reduced cost of travel
(85%) and reduced time away from home or work (65%) as the benefits that would make
them prefer mobile teledermatology consultations over face-to-face consultations, while
13% of patients stated that they would not prefer mobile teledermatology consultations over
face-to-face interaction with a dermatologist.
Our results provide insight into the demographics of the adult HIV positive population seen
by the dermatology service in Gaborone and surrounding areas. A greater proportion of our
patients (56%) were female, which reflects the national gender disparity in the prevalence of
HIV. The median age of our cohort was 39 years, which is consistent with the age of peak
prevalence of HIV nationally. Unlike national estimates however, most of our patients were
J Telemed Telecare. Author manuscript.
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single (71%), whereas the national HIV prevalence is highest in those who are widowed
(40%).[12] In the context of a severe shortage of dermatology providers in Botswana, our
results emphasise the difficulties these patients often encounter in obtaining dermatology
care, including distance, cost and time as barriers to care. Furthermore, patients viewed
mobile teledermatology as an acceptable alternative to obtaining skin care from a face-toface consultation with a dermatologist.
Our study had several limitations. The survey questions were not extensively validated. The
questions were vetted by several dermatologists and other physicians and epidemiologists
who all agreed on the importance of the inclusion of each question, which provides our
instrument with some measure of content validity. The questions covered the dimensions
recommended by Demiris et al. in their systematic review of patient acceptability studies in
teledermatology.[8] Another limitation was the generalizability of our findings, since the
results were obtained in HIV-positive adult patients in Botswana. However, it is reassuring
to note that our cohort of patients was fairly representative of the general HIV-positive
population in Botswana in terms of age and gender distributions. Finally, our patients were
given compensation to help defray transportation costs, which may have led to response
bias. However, such compensation is common in many studies.
Overall, mobile teledermatology consultations were well accepted by HIV-positive patients
with mucocutaneous conditions in Botswana. Most patients said that mobile teledermatology
consultations for all parts of their body would be acceptable. Patients were most sensitive
about the transmission of facial lesions through mobile teledermatology. However, even
patients who cited concerns about the transmission of identifiable facial photographs
consented to mobile teledermatology evaluations of facial lesions, so long as care was taken
to minimize the possibility of recognition.
Previous studies have assessed patient satisfaction with traditional store-and-forward
teleconsultation in remote settings. [13] To our knowledge, this is the first study to address
patient acceptance of mobile teledermatology in a population with a potentially stigmatizing
underlying illness such as HIV. Given the rapid growth of mobile phone networks in
developing countries, mobile teledermatology may be increasingly used to provide skin care
in underserved communities. Our study demonstrates that HIV-positive patients find this
technology acceptable for specialist consultations when face-to-face consultations may be
difficult to obtain.
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Table 1

Characteristics of the study population
No (%)
Patients screened

89

Patients enrolled

77 (87)

95% CI (in %)

Patients completing the survey

75 (97)

Male

34 (44)

31–53

Female

43 (56)

47–69

39

IQR 32–45

Single

54 (71)

61–81

Married

17 (22)

13–32

Widowed

3 (4)

0–6

Divorced

2 (1)

0–8

Median age (y)
Marital status

Recruitment site
Independence surgery

17 (22)

PMH medical

21 (27)

PMH oncology

23 (29)

PMH dermatology clinic

14 (18)

PMH Infectious Disease Care Centre

1 (1)

Lobatse

2 (3)

Site of regular skin care
Gaborone

44 (57)

Outside Gaborone

30 (39)

None

3 (4)

Employment status
Employed

42 (56)

Unemployed

33 (44)

Retired

1 (1)
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Table 2

Barriers to dermatology care and attitudes towards mobile teledermatology

What were the difficulties in seeking medical care for your skin
condition?
Too costly
Takes too much time
Getting permission to leave home work

No (%)

95% CI (in %)

43 (57)

46–69

57 (76)

66–86

3 (4)

0–9

31 (41)

30–53

Too far

1 (1)

0–4

Shyness

7 (9)

3–16

2 (3)

0–8

<1

29 (45)

33–58

1–3 (includes:“long hours”, “many hours”

33 (53)

39–64

13

-

6 (8)

2–15

Something else (including ”Doctor too booked”, “not enough
Doctors”, “First time seeing Doctor”)
How many hours of your day does it take to see a skin doctor
(round-trip)?

>3 (includes: “forever, “the whole day”)
Missing (includes: “never saw one”, "never had skin
problems” “?”)
What is your greatest concern regarding mobile teledermatology
consultation?
Not having face-to-face interaction with doctor

2 (3)

0–7

Getting the wrong or worse treatment

6 (8)

2–15

Incomplete representation/bad picture
Privacy
None

2 (3)

0–7

60 (82)

73–91

4 (-)

Missing
Do you believe that you will receive the same treatment/quality
of care via mobile teledermatology as face-to-face (FTF)
consultation?
Yes

67 (91)

84–97

5 (7)
14 (19)

1–13
10–28

Prefer FTF consultation

29 (40)

28–51

None - i.e. want the answer on the same day

How many days would you be willing to wait to get a response
from the mobile teledermatology in exchange for the
convenience of not having to travel far or wait for a FTF
consultation?

20 (27)

17–38

1–3 days

3 (4)

0–9

1 week

2 (3)

0–7

Face

43 (58)

47–70

Chest

70 (97)

93–100

More than one week, less than 1 month
1 month or more
Are the following sites acceptable for photography?*
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No (%)

95% CI (in %)

Genital

66 (92)

85–98

Legs

69 (96)

91–100

Body

69 (95)

88–100

61 (85)

76–93

Which benefits would make you prefer mobile teledermatology
over FTF consultation?
Reduced cost of travel

47 (65)

53–76

Reduced time away from home or work

4 (6)

0–11

Better treatment or quality of care

9 (13)

5–21

Would not prefer mobile phone over face-to-face
*

Every patient who reported non-acceptance cited privacy as their concern.
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